Middle East and Africa Pharmaceutical Glass Packaging Market, By Material (Type I, Type II, and Type III), Product (Bottles, Ampoules, Cartridges and Syringes, Vials, and Others), Drug Type (Generic, Branded, and Biologic) Application (Oral, Injectable, Nasal, and Others), End-Use (Pharmaceutical Companies, Biopharmaceutical Companies, Contract Development, and Manufacturing Companies, Compound Pharmacy, and Others) – Industry Trends and Forecast to 2030.
Middle East and Africa Pharmaceutical Glass Packaging Market Analysis and Size
The Middle East and Africa pharmaceutical glass packaging market is experiencing dynamic growth, driven by several compelling factors. The rising demand for pharmaceutical products in the region, attributed to population growth and improved healthcare access, is a significant driver. Glass packaging, known for preserving drug efficacy and ensuring safety, is increasingly preferred to meet this growing demand.
Data Bridge Market Research analyses that the pharmaceutical glass packaging market which was USD 3,01,589.61 thousand in 2022, is expected to USD 5,38,147.13 thousand by 2030, and is expected to undergo a CAGR of 7.1% during the forecast period of 2023 to 2030. “Type I” segment in the material segment dominates the pharmaceutical glass packaging market due to its high hydrolytic resistance and suitability for parenteral packaging and its use in sterile injectable, vaccines, and biologics. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.
Middle East and Africa Pharmaceutical Glass Packaging Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Thousand, Volumes in Tons, Pricing in USD
|
|
Segments Covered
|
Material (Type I, Type II, and Type III), Product (Bottles, Ampoules, Cartridges and Syringes, Vials, and Others), Drug Type (Generic, Branded, and Biologic) Application (Oral, Injectable, Nasal, and Others), End-Use (Pharmaceutical Companies, Biopharmaceutical Companies, Contract Development, and Manufacturing Companies, Compound Pharmacy, and Others)
|
|
Countries Covered
|
U.A.E., Saudi Arabia, Egypt, South Africa, Israel, and Africa and the rest of Middle East and Africa
|
|
Market Players Covered
|
RAK Ghani Glass LLC (U.A.E.), APG (Asia Pulp & Paper Group) (Indonesia), Middle East Glass – MEG (Egypt), Bormioli Pharma S.p.a (Italy), FRIGOGLASS AG (Switzerland), and Medicinal Glass CO., Ltd. (China)
|
|
Market Opportunities
|
|
Market Definition
Pharmaceutical glass packaging is essential in the pharmaceutical industry, serving as a reliable means to store, protect, and distribute drugs and medical products. Its inert properties maintain drug stability, preventing interactions that could compromise efficacy. Glass acts as a strong barrier against moisture and contaminants while offering transparency for visual inspection. It's a preferred choice for sterile drug storage, thanks to easy sterilization and tamper-resistant features.
Glass packaging finds applications in liquid medications, sterile injectables, tablets, capsules, diagnostic reagents, and more. Its recyclability aligns with sustainability goals, making pharmaceutical glass packaging a vital component in ensuring the quality and safety of pharmaceutical products.
Middle East and Africa Pharmaceutical Glass Packaging Market Dynamics
Drivers
- Rising Pharmaceutical Demand
The Middle East and Africa pharmaceutical glass packaging market is driven by the increasing demand for pharmaceutical products in the region. Factors such as population growth, aging demographics, and improved access to healthcare services are boosting the consumption of medications. As a result, the need for reliable and sterile packaging solutions like glass vials and ampoules is on the rise, ensuring drug efficacy and safety.
- Stringent Regulatory Standards
The stringent regulatory environment in the pharmaceutical sector is a significant driver for glass packaging. Regulatory authorities in the region emphasize product safety and quality. Glass, particularly Type I glass, is preferred due to its inert properties, ensuring drug stability and minimizing the risk of contamination. This regulatory focus drives pharmaceutical companies to adopt pharmaceutical glass packaging to comply with quality standards and gain approval for their products.
- Growing Biopharmaceutical Industry
The expanding biopharmaceutical industry in the Middle East and Africa presents a driver for specialized glass packaging. Biologics, such as monoclonal antibodies and vaccines, require precise storage and distribution, making glass containers like vials and syringes essential for their packaging. As the biopharmaceutical sector continues to grow, so does the demand for pharmaceutical glass packaging solutions tailored to these sensitive products.
Opportunities
- Sustainable Packaging Trends
The Middle East and Africa pharmaceutical glass packaging market has an opportunity to capitalize on the growing global trend towards sustainable packaging solutions. Glass is inherently recyclable and eco-friendly, aligning with increasing consumer and regulatory demands for environmentally responsible choices. Manufacturers can invest in innovative, sustainable glass packaging options to meet these demands.
- Growing Technological Advancements
Opportunities arise from technological advancements in glass manufacturing. Innovations such as improved glass compositions for better barrier properties and enhanced manufacturing processes can lead to more cost-effective, durable, and user-friendly glass packaging solutions. These advancements can make glass even more competitive and attractive in the pharmaceutical packaging sector.
Restraints/ Challenges
- Rising Cost Considerations
One of the primary restraints for the Middle East and Africa pharmaceutical glass packaging market is the relatively higher cost of glass packaging compared to alternative materials such as plastic. Cost-sensitive markets may hesitate to adopt glass, especially for high-volume, low-margin pharmaceutical products, posing a restraint on market growth.
- Increasing Supply Chain Vulnerabilities
The region's pharmaceutical supply chain can be vulnerable to disruptions, including logistics challenges and geopolitical factors. Glass packaging materials can be fragile and require careful handling, making them susceptible to supply chain disruptions. Such vulnerabilities can hinder the availability and affordability of glass packaging.
- Competition from Alternatives
The Middle East and Africa pharmaceutical glass packaging market faces competition from alternative packaging materials such as plastic and polymer-based solutions. These materials offer lighter weight and reduced breakage risk, potentially appealing to cost-conscious pharmaceutical companies. Convincing stakeholders of the long-term benefits of glass packaging can be challenging.
- Customization and Innovation
Meeting the diverse needs of pharmaceutical manufacturers in terms of packaging design, customization, and innovation can be a challenge. Pharmaceutical companies may require specialized glass containers for specific drug formulations or delivery methods, necessitating continuous innovation and flexibility in glass packaging solutions to address these demands effectively.
This pharmaceutical glass packaging market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Pharmaceutical Glass Packaging market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In May 2023, Nipro PharmaPackaging International NV, a subsidiary of Japan-based Nipro Corporation, has acquired Piramida, a leading Croatian glass pharmaceutical packaging producer. Recognizing Piramida's remarkable growth under Blue Sea Capital's ownership, the acquisition demonstrates Nipro's commitment to expanding its presence in European and global pharmaceutical packaging markets. This aligns with a broader trend of strategic acquisitions reshaping the industry landscape
Middle East and Africa Pharmaceutical Glass Packaging Market Scope
The pharmaceutical glass packaging market are segmented on the basis of the material, product, drug type, application, and end-use. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Material
- Type I
- Type II
- Type III
Product
- Bottles
- Ampoules
- Cartridges and Syringes
- Vials
- Others
Drug Type
- Generic
- Branded
- Biologic
Application
- Oral
- Injectable
- Nasal
- Others
End-Use
- Pharmaceutical Companies
- Biopharmaceutical Companies
- Contract Development
- Manufacturing Companies
- Compound Pharmacy
- Others
Pharmaceutical Glass Packaging Market Regional Analysis/Insights
The pharmaceutical glass packaging market is analysed and market size insights and trends are provided by material, product, drug type, application, and end-use as referenced above.
The countries covered in the pharmaceutical glass packaging market report areU.A.E., Saudi Arabia, Egypt, South Africa, Israel, and Africa and the rest of Middle East and Africa.
U.A.E. dominates the pharmaceutical glass packaging market due to the growing urbanization and increasing consumer awareness regarding different pharmaceutical glass packaging products.
Saudi Arabia is expected to witness the highest growth in the forecast period due to the increasing consumption of pharmaceutical glass packaging in the pharmaceutical industry
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and up-stream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of the global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Pharmaceutical Glass Packaging Market Share Analysis
The pharmaceutical glass packaging market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the company's focus related to pharmaceutical glass packaging market.
Some of the major players operating in the pharmaceutical glass packaging market are:
- RAK Ghani Glass LLC (U.A.E.)
- APG (Asia Pulp & Paper Group) (Indonesia)
- Middle East Glass – MEG (Egypt)
- Bormioli Pharma S.p.a (Italy)
- FRIGOGLASS AG (Switzerland)
- Medicinal Glass CO., Ltd. (China)
SKU-